Selected research
Market Structure
Global Oxycodone Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oxycodone Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oxycodone Hydrochloride Injection include LTL Pharma Co., Ltd., NAPP PHARMACEUTICALS LIMITED, Organon LLC, Sumitomo Pharma America, Inc., Teva Takeda Yakuhin Ltd., Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Mylan Pharmaceuticals and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Oxycodone Hydrochloride Injection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oxycodone Hydrochloride Injection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oxycodone Hydrochloride Injection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oxycodone Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Oxycodone Hydrochloride Injection Segment by Company
LTL Pharma Co., Ltd.
NAPP PHARMACEUTICALS LIMITED
Organon LLC
Sumitomo Pharma America, Inc.
Teva Takeda Yakuhin Ltd.
Santen Pharmaceutical Co.,Ltd.
Hengrui Medicine
Mylan Pharmaceuticals
Teva Pharmaceutical Industries
Oxycodone Hydrochloride Injection Segment by Type
2ml:20mg
1ml:10mg
Oxycodone Hydrochloride Injection Segment by Application
Hospital
Clinic
Others
Oxycodone Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oxycodone Hydrochloride Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxycodone Hydrochloride Injection industry.
Chapter 3: Detailed analysis of Oxycodone Hydrochloride Injection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Injectionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2ml:20mg
- 1ml:10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- LTL Pharma Co., Ltd.
- NAPP PHARMACEUTICALS LIMITED
- Organon LLC
- Sumitomo Pharma America, Inc.
- Teva Takeda Yakuhin Ltd.
- Santen Pharmaceutical Co.,Ltd.
- Hengrui Medicine
- Mylan Pharmaceuticals
- Teva Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 2ml:20mg
- 1.2.3 1ml:10mg
- 1.3 Market Analysis by Application
- 1.3.1 Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Oxycodone Hydrochloride Injection Growth Trends by Region
- 1.5.1 Global Oxycodone Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Oxycodone Hydrochloride Injection Market Size by Region (2021-2026)
- 1.5.3 Oxycodone Hydrochloride Injection Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Oxycodone Hydrochloride Injection Market Dynamics
- 2.1 Oxycodone Hydrochloride Injection Industry Trends
- 2.2 Oxycodone Hydrochloride Injection Industry Drivers
- 2.3 Oxycodone Hydrochloride Injection Industry Opportunities and Challenges
- 2.4 Oxycodone Hydrochloride Injection Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Oxycodone Hydrochloride Injection Revenue by Company (2021-2026)
- 3.2 Global Oxycodone Hydrochloride Injection Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Oxycodone Hydrochloride Injection Key Company Head office and Area Served
- 3.4 Global Oxycodone Hydrochloride Injection Company, Product Type & Application
- 3.5 Global Oxycodone Hydrochloride Injection Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Oxycodone Hydrochloride Injection Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Oxycodone Hydrochloride Injection Players Market Share by Revenue in 2025
- 3.6.3 2025 Oxycodone Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Oxycodone Hydrochloride Injection Market by Type
- 4.1 Global Oxycodone Hydrochloride Injection Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Oxycodone Hydrochloride Injection Market Size by Type (2021-2032)
- 4.3 Global Oxycodone Hydrochloride Injection Market Size Share by Type (2021-2032)
5 Oxycodone Hydrochloride Injection Market by Application
- 5.1 Global Oxycodone Hydrochloride Injection Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Oxycodone Hydrochloride Injection Market Size by Application (2021-2032)
- 5.3 Global Oxycodone Hydrochloride Injection Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 LTL Pharma Co., Ltd.
- 6.1.1 LTL Pharma Co., Ltd. Company Information
- 6.1.2 LTL Pharma Co., Ltd. Business Overview
- 6.1.3 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.1.5 LTL Pharma Co., Ltd. Recent Developments
- 6.2 NAPP PHARMACEUTICALS LIMITED
- 6.2.1 NAPP PHARMACEUTICALS LIMITED Company Information
- 6.2.2 NAPP PHARMACEUTICALS LIMITED Business Overview
- 6.2.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product Portfolio
- 6.2.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
- 6.3 Organon LLC
- 6.3.1 Organon LLC Company Information
- 6.3.2 Organon LLC Business Overview
- 6.3.3 Organon LLC Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Organon LLC Oxycodone Hydrochloride Injection Product Portfolio
- 6.3.5 Organon LLC Recent Developments
- 6.4 Sumitomo Pharma America, Inc.
- 6.4.1 Sumitomo Pharma America, Inc. Company Information
- 6.4.2 Sumitomo Pharma America, Inc. Business Overview
- 6.4.3 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product Portfolio
- 6.4.5 Sumitomo Pharma America, Inc. Recent Developments
- 6.5 Teva Takeda Yakuhin Ltd.
- 6.5.1 Teva Takeda Yakuhin Ltd. Company Information
- 6.5.2 Teva Takeda Yakuhin Ltd. Business Overview
- 6.5.3 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.5.5 Teva Takeda Yakuhin Ltd. Recent Developments
- 6.6 Santen Pharmaceutical Co.,Ltd.
- 6.6.1 Santen Pharmaceutical Co.,Ltd. Company Information
- 6.6.2 Santen Pharmaceutical Co.,Ltd. Business Overview
- 6.6.3 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.6.5 Santen Pharmaceutical Co.,Ltd. Recent Developments
- 6.7 Hengrui Medicine
- 6.7.1 Hengrui Medicine Company Information
- 6.7.2 Hengrui Medicine Business Overview
- 6.7.3 Hengrui Medicine Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Hengrui Medicine Oxycodone Hydrochloride Injection Product Portfolio
- 6.7.5 Hengrui Medicine Recent Developments
- 6.8 Mylan Pharmaceuticals
- 6.8.1 Mylan Pharmaceuticals Company Information
- 6.8.2 Mylan Pharmaceuticals Business Overview
- 6.8.3 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product Portfolio
- 6.8.5 Mylan Pharmaceuticals Recent Developments
- 6.9 Teva Pharmaceutical Industries
- 6.9.1 Teva Pharmaceutical Industries Company Information
- 6.9.2 Teva Pharmaceutical Industries Business Overview
- 6.9.3 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product Portfolio
- 6.9.5 Teva Pharmaceutical Industries Recent Developments
7 North America
- 7.1 North America Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 7.2 North America Oxycodone Hydrochloride Injection Market Size by Type
- 7.2.1 North America Oxycodone Hydrochloride Injection Market Size by Type (2021-2026)
- 7.2.2 North America Oxycodone Hydrochloride Injection Market Size by Type (2027-2032)
- 7.2.3 North America Oxycodone Hydrochloride Injection Market Share by Type (2021-2032)
- 7.3 North America Oxycodone Hydrochloride Injection Market Size by Application
- 7.3.1 North America Oxycodone Hydrochloride Injection Market Size by Application (2021-2026)
- 7.3.2 North America Oxycodone Hydrochloride Injection Market Size by Application (2027-2032)
- 7.3.3 North America Oxycodone Hydrochloride Injection Market Share by Application (2021-2032)
- 7.4 North America Oxycodone Hydrochloride Injection Market Size by Country
- 7.4.1 North America Oxycodone Hydrochloride Injection Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 7.4.3 North America Oxycodone Hydrochloride Injection Market Size by Country (2027-2032)
- 7.4.4 North America Oxycodone Hydrochloride Injection Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 8.2 Europe Oxycodone Hydrochloride Injection Market Size by Type
- 8.2.1 Europe Oxycodone Hydrochloride Injection Market Size by Type (2021-2026)
- 8.2.2 Europe Oxycodone Hydrochloride Injection Market Size by Type (2027-2032)
- 8.2.3 Europe Oxycodone Hydrochloride Injection Market Share by Type (2021-2032)
- 8.3 Europe Oxycodone Hydrochloride Injection Market Size by Application
- 8.3.1 Europe Oxycodone Hydrochloride Injection Market Size by Application (2021-2026)
- 8.3.2 Europe Oxycodone Hydrochloride Injection Market Size by Application (2027-2032)
- 8.3.3 Europe Oxycodone Hydrochloride Injection Market Share by Application (2021-2032)
- 8.4 Europe Oxycodone Hydrochloride Injection Market Size by Country
- 8.4.1 Europe Oxycodone Hydrochloride Injection Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 8.4.3 Europe Oxycodone Hydrochloride Injection Market Size by Country (2027-2032)
- 8.4.4 Europe Oxycodone Hydrochloride Injection Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 9.2 China Oxycodone Hydrochloride Injection Market Size by Type
- 9.2.1 China Oxycodone Hydrochloride Injection Market Size by Type (2021-2026)
- 9.2.2 China Oxycodone Hydrochloride Injection Market Size by Type (2027-2032)
- 9.2.3 China Oxycodone Hydrochloride Injection Market Share by Type (2021-2032)
- 9.3 China Oxycodone Hydrochloride Injection Market Size by Application
- 9.3.1 China Oxycodone Hydrochloride Injection Market Size by Application (2021-2026)
- 9.3.2 China Oxycodone Hydrochloride Injection Market Size by Application (2027-2032)
- 9.3.3 China Oxycodone Hydrochloride Injection Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 10.2 Asia Oxycodone Hydrochloride Injection Market Size by Type
- 10.2.1 Asia Oxycodone Hydrochloride Injection Market Size by Type (2021-2026)
- 10.2.2 Asia Oxycodone Hydrochloride Injection Market Size by Type (2027-2032)
- 10.2.3 Asia Oxycodone Hydrochloride Injection Market Share by Type (2021-2032)
- 10.3 Asia Oxycodone Hydrochloride Injection Market Size by Application
- 10.3.1 Asia Oxycodone Hydrochloride Injection Market Size by Application (2021-2026)
- 10.3.2 Asia Oxycodone Hydrochloride Injection Market Size by Application (2027-2032)
- 10.3.3 Asia Oxycodone Hydrochloride Injection Market Share by Application (2021-2032)
- 10.4 Asia Oxycodone Hydrochloride Injection Market Size by Country
- 10.4.1 Asia Oxycodone Hydrochloride Injection Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 10.4.3 Asia Oxycodone Hydrochloride Injection Market Size by Country (2027-2032)
- 10.4.4 Asia Oxycodone Hydrochloride Injection Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Type
- 11.2.1 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Application
- 11.3.1 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country
- 11.4.1 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Oxycodone Hydrochloride Injection Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst